Clinical Trial: A Study to Test How Well Different Doses of BI 765250 Are Tolerated by People With a Skin Disease Called Plaque Psoriasis
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Psoriasis
Study Type: INTERVENTIONAL
Official Title: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous and Subcutaneous Multiple Rising Doses of BI 765250 Versus Placebo in Trial Participants With Moderate to Severe Plaque Psor
Brief Summary:
This study is open to adults with plaque psoriasis.The main purpose of this study is to find out whether people with plaque psoriasis can tolerate a medicine called BI 765250.Another purpose is to check whether BI 765250 can improve participants' skin condition.Participants are divided into 5 groups.Each group gets a different dose of BI 765250 or placebo as an infusion or injection for 12 weeks.Placebo infusions and injections look like BI 765250 but do not contain any medicine.It is decided by chance, who…
Read more